Subscribe to Newsletter
Inside the Lab Precision medicine, Oncology, Laboratory management

Personalized medicine – in vitro drug testing on primary cancer cells

sponsored by Tecan

Personalized treatments have the greatest potential to benefit cancer patients. Guided selection of the most suitable drug or combination of drugs for a specific patient’s cancer profile avoids a trial-and-error treatment strategy.

In this context, many university hospitals house dedicated research groups to screen small, dedicated drug libraries on primary tumor cells derived from patient biopsies to match potential treatments to different cancer types.

In this eBook we have compiled examples of such laboratories working in the area of pediatric oncology. They all share a reliance on miniaturization and fast processing times to screen hundreds of compounds on very limited and precious patient material.

Download the ebook

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine